For the quarter ended December 2025, Omada Health, Inc. (OMDA) reported revenue of $75.85 million, representing no change compared to the same period last year. EPS came in at $0.13, compared to $0 in the year-ago quarter.
The reported revenue represents a surprise of +3.9% over the Zacks Consensus Estimate of $73 million. With the consensus EPS estimate being $0.03, the EPS surprise was +420%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Omada Health, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total Members: 886,000 versus the two-analyst average estimate of 860,009.
- Revenue- Services: $71.65 million versus $64.53 million estimated by two analysts on average.
- Revenue- Hardware: $4.2 million versus $4.96 million estimated by two analysts on average.
View all Key Company Metrics for Omada Health, Inc. here>>>
Shares of Omada Health, Inc. have returned +0.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Omada Health, Inc. (OMDA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
